10 newer rulings cite the same tariff codes.
Classification can shift over time. Review the more recent rulings below before relying on this one.
The tariff classification of Spironolactone Tablets in dosage form, from China
Issued July 11, 2023 by U.S. Customs and Border Protection.
Cite this ruling
Copies to clipboardN3 N333556 (July 11, 2023)
Tariff classification
HTS codes: 3004.39.0050
Headings: 3004
Product description
Spironolactone Tablets, imported in 25 mg, 50 mg, and 100 mg, is an aldosterone receptor antagonist. It is indicated for the treatment of hypertension, hyperaldosteronism, edema due to various conditions, hirsutism (off-label) and hypokalemia. In your letter,
CBP rationale
The applicable subheading for the Spironolactone Tablets in dosage form will be 3004.39.0050, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other, containing hormones or other products of heading 2937: Other: Other.
Full text
N333556 July 11, 2023 CLA-2-30:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 3004.39.0050 Liam O'Connor NorthStar Healthcare 3300 Cork Airport Business Park, Kinsale Road Cork Ireland RE: The tariff classification of Spironolactone Tablets in dosage form, from China Dear Mr. O'Connor: In your letter dated June 15, 2023, you requested a tariff classification ruling. Spironolactone Tablets, imported in 25 mg, 50 mg, and 100 mg, is an aldosterone receptor antagonist. It is indicated for the treatment of hypertension, hyperaldosteronism, edema due to various conditions, hirsutism (off-label) and hypokalemia. In your letter, you stated Spironolactone Tablets will be exported from India. The applicable subheading for the Spironolactone Tablets in dosage form will be 3004.39.0050, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other, containing hormones or other products of heading 2937: Other: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs and Border Protection Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, please contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification and country of origin of Calcitonin Salmon Injection, USP in dosage form
The tariff classification of Leuprolide Acetate Injection in dosage form, from India
The tariff classification of Liraglutide Injection Pen in dosage form, from China
The tariff classification of ORABLOC® (Articaine Hydrochloride 4% and Epinephrine 1100,000 and 1200,000) Injection in dosage form, from Italy
The tariff classification of Estradiol Tablets in dosage form, from India
The tariff classification of Exemestane Tablets in dosage form, from China
The tariff classification of Exemestane Tablets in dosage form, from India
The tariff classification of Levothyroxine Sodium for Injection in dosage form, from India
The tariff classification of Levothyroxine Sodium Tablets in dosage form, from India
The tariff classification of Abiraterone Acetate Tablets in dosage form, from China
Follow N333556
Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.
One email per day at most. Confirm your address once, unsubscribe anytime.
Searching CBP rulings the smart way
Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.